Guided Therapeutics (GTHP) Preferred Stock Liabilities (2013 - 2021)

Guided Therapeutics (GTHP) has 8 years of Preferred Stock Liabilities data on file, last reported at $50000.0 in Q2 2021.

• For the quarter ending Q2 2021, Preferred Stock Liabilities changed N/A year-over-year to $50000.0; the trailing twelve-month figure through Jun 2021 stood at $50000.0 (changed N/A YoY), and the FY2019 full-year result was $105000.0, changed 0.0% from the prior year.
• Preferred Stock Liabilities fell to $50000.0 in Q2 2021, from $125000.0 in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $701000.0 in Q1 2017 to a low of $50000.0 in Q2 2021.
• A 4-year average of $306000.0 and a median of $125000.0 in 2021 frame the typical range for Preferred Stock Liabilities.
• Across the five-year window, Preferred Stock Liabilities slumped 70.42% in 2018 and changed 0.0% in 2019, its largest moves.
• Tracing GTHP's Preferred Stock Liabilities over 4 years: stood at $355000.0 in 2017, then tumbled by 70.42% to $105000.0 in 2018, then changed by 0.0% to $105000.0 in 2019, then slumped by 52.38% to $50000.0 in 2021.
• Business Quant data shows GTHP's Preferred Stock Liabilities at $50000.0 in Q2 2021, $125000.0 in Q1 2021, and $105000.0 in Q4 2019.